Core Insights - Neogen Corporation (NASDAQ:NEOG) is facing a voluntary recall of its Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution due to microbial contamination in certain lots, which has led to adverse events reported in horses [1][2] - The company reported a revenue of $224.7 million for fiscal Q2 2026, reflecting a 2.8% year-over-year decline, while core growth increased by 2.9% year-over-year [3] Recall Details - The recall affects all lots within expiry of the 10 mL/50 mg product vials and includes the 2 mL/20 mg product vials as a precautionary measure [1][2] - Neogen Corporation is collaborating with the FDA regarding the recall and ongoing investigation into the adverse events [2] Financial Performance - The net loss for the quarter was reported at $15.9 million, with an adjusted net income of $22.6 million [3] - The company's operations are segmented into Food Safety and Animal Safety, indicating a diversified portfolio in the safety products market [3]

Core Viewpoint - The article discusses the best pet stocks to buy according to hedge funds, highlighting the methodology used to select these stocks and providing insights into their performance and market sentiment [5][7][8]. Group 1: Market Trends and Insights - Tom Lee of Fundstrat noted that the stock market has faced challenges due to a software downturn and a shift in investment focus, but earnings reports have been solid, indicating potential for recovery [2][4]. - Lee emphasized that many companies have exceeded earnings expectations, particularly in the small-cap sector, suggesting that the market has not fully appreciated the strength of the earnings season [3][4]. - He identified three key trades for the future: a rotation back to major tech stocks, potential bottoms in software stocks, and cryptocurrency [4]. Group 2: Methodology for Stock Selection - The article explains that the selection of the best pet stocks was based on data from the Finviz stock screener and financial media reports, focusing on the top 10 stocks favored by elite hedge funds as of Q3 2025 [7]. - The research indicates that imitating the stock picks of successful hedge funds can lead to market outperformance, with a reported return of 427.7% since May 2014 [8]. Group 3: Company-Specific Insights - **Spectrum Brands Holdings, Inc. (NYSE:SPB)**: - The company has received multiple price target increases, with RBC Capital and Oppenheimer both raising their targets to $85, citing strong fiscal Q1 revenue of $677 million, which exceeded estimates [10][11]. - Canaccord also raised its price target to $94, highlighting that the company’s fiscal Q1 results showed sales and adjusted EBITDA above consensus expectations [12][13]. - **Neogen Corporation (NASDAQ:NEOG)**: - The company is recalling certain products due to microbial contamination, which has raised concerns following reports of adverse events in horses [14][15]. - Neogen reported a revenue of $224.7 million for fiscal Q2 2026, reflecting a 2.8% year-over-year decline, while core growth was up 2.9% [16].

Core Viewpoint - Neogen Corporation is voluntarily recalling all lots of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution due to microbial contamination, affecting its use in dogs, cats, and horses [1] Group 1: Recall Details - The recall includes all lots within expiry of the product [1] - The product is distributed by Neogen and manufactured by a third-party supplier [1] - The recall was initiated following reports of adverse events in horses [1]